Sub-acute and long-term effects of ayahuasca on mental health and well-being in healthy ceremony attendants: A replication study
Kim van Oorsouw, Malin V. Uthaug, Natasha L. Mason, Nick J. Broers, Johannes G. Ramaekers
Journal of Psychedelic Studies August 26, 2021 DOI: 10.1556/2054.2021.00174 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational cohort Placebo-controlled Peer reviewed |
|---|---|
| Sample size | 73 |
| Population | Ayahuasca ceremony attendants (first-time and experienced users) |
| Intervention | Ayahuasca |
| Duration | 4-week follow-up |
| Topics | Anxiety Ayahuasca |
| Keywords | Mental health Ceremony Depression economics Clinical psychology |
| Citations | 16 |
| Key findings | Ayahuasca produced long-term improvements in stress, anxiety, and somatization, but not depression, in non-clinical users. |
Abstract
Abstract Background and aims There is a growing body of evidence suggesting that the psychedelic plant tea, ayahuasca, holds therapeutic potential. Uthaug et al. (2018) demonstrated that a single dose of ayahuasca improved mental health sub-acutely and 4-weeks post-ceremony in healthy participants. The present study aimed to replicate and extend these findings. A first objective was to assess the sub-acute and long-term effects of ayahuasca on mental health and well-being in first-time and experienced users. A second aim was to extend the assessment of altered states of consciousness and how they relate to changes in mental health.
Method: Ayahuasca ceremony attendants ( N = 73) were assessed before, the day after, and four weeks following the ceremony.
Results: We replicated the reduction in self-reported stress 4-weeks post ceremony, but, in contrast, found no reduction in depression. Also, increased satisfaction with life and awareness the day after the ceremony, and its return to baseline 4 weeks later, were replicated. New findings were: reduced ratings of anxiety and somatization, and increased levels of non-judging 4-weeks post-ceremony. We replicated the relation between altered states of consciousness (e.g., experienced ego dissolution during the ceremony) and mental health outcomes sub-acutely. The effects of ayahuasca did not differ between experienced and first-time users.
Conclusion: Partly in line with previous findings, ayahuasca produces long-term improvements in affect in non-clinical users. Furthermore, sub-acute mental health ratings are related to the intensity of the psychedelic experience. Although findings replicate and highlight the therapeutic potential of ayahuasca, this needs to be confirmed in placebo-controlled studies.
Comparable studies
Other observational and cohort studies on ayahuasca for anxiety, most cited first.
Citations in the library
Cited by 16
- Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey. PLOS global public health 2022
- Persisting Effects of Ayahuasca on Empathy, Creative Thinking, Decentering, Personality, and Well-Being Frontiers in Pharmacology October 1, 2021
- Therapeutic effect of an ayahuasca analogue in clinically depressed patients: a longitudinal observational study. Psychopharmacology January 24, 2022
- Changes in mental health, wellbeing and personality following ayahuasca consumption: Results of a naturalistic longitudinal study. Frontiers in Pharmacology 2022
- A landscape analysis of psychedelic retreat organizations advertising online PLoS One May 2, 2025
and 11 more in the library
Cites 39
- Using Self-Report Assessment Methods to Explore Facets of Mindfulness Assessment January 27, 2006
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder JAMA Psychiatry November 4, 2020
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Psychopharmacology December 1, 2011
- Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial Psychological Medicine June 15, 2018
and 34 more in the library